Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Cholangiocarcinoma”

438 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 438 results

Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Testing effectiveness (Phase 2)Ended earlyNCT02452970
What this trial is testing

RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy

Who this might be right for
Cholangiocarcinoma
EpicentRx, Inc. 4
Not applicableUnknownNCT05697237
What this trial is testing

Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University 60
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Not applicableUnknownNCT05215665
What this trial is testing

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 146
Testing effectiveness (Phase 2)Looking for participantsNCT07398339
What this trial is testing

Cosiporfin Sodium for Injection Photodynamic Therapy

Who this might be right for
Biliary Tract Cancers (BTC)
Shanghai Guangsheng Biopharmaceutical Co., Ltd 30
Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07147088
What this trial is testing

Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma.

Who this might be right for
Advanced Intrahepatic Cholangiocarcinoma
Fudan University 36
Testing effectiveness (Phase 2)Ended earlyNCT01855724
What this trial is testing

Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

Who this might be right for
CholangiocarcinomaGallbladder CarcinomaBiliary Carcinoma
Hellenic Cooperative Oncology Group 29
Early research (Phase 1)Ended earlyNCT05814536
What this trial is testing

IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor

Who this might be right for
Cholangiocarcinoma With IDH1 MutationSolid Tumors With IDH1 Mutation
AnHeart Therapeutics Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT04299581
What this trial is testing

Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Early research (Phase 1)WithdrawnNCT05510427
What this trial is testing

Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification

Who this might be right for
CholangiocarcinomaLiver Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05009953
What this trial is testing

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+1 more
CSPC Ouyi Pharmaceutical Co., Ltd. 17
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05876754
What this trial is testing

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Servier Affaires Médicales 299
Early research (Phase 1)Ended earlyNCT02012231
What this trial is testing

Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.

Who this might be right for
MelanomaThyroid CancerColorectal Cancer+4 more
Fore Biotherapeutics 5
Next Page